Dolores-Velázquez R, Padilla-Rosciano A, Cuéllar-Hubbe M, Durán-Hernández M, Pérez-Montiel D, Martínez-Said H

Language: Spanish
References: 17
Page: 475-480
PDF size: 152.14 Kb.

ABSTRACT

Most patients with thyroid bone metastases have been evaluated in accordance with other sites of disease. Overall survival is impacted and the results with surgery, radiation therapy, or radioactive iodine show variable results. Four cases are presented: three women and one man with an age range of 43-53 years and all with radical surgery. Good local control in three of the patients was observed. All patients had hormonal suppression with levothyroxine. Radical surgery showed an improvement in survival in patients with bone metastases for thyroid carcinoma.

REFERENCES

1. Schlumberger MJ. Medical progress: papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.

2. 2. Degroot LJ, Kaplan EL, McCormick M, Strauss FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.

3. 3. Zettinig G, Fueguer JB, Passlert C, Kaserer K, Pirich C, Dudczak R, Niederle B. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma¾surgery or conventional therapy? Clin Endocrinol 2002;56:377-382.

4. 4. Galloway RJ, Smalridge RC. Imaging in thyroid cancer. Endocrinol Metab Clin North Am 1996;25(1):93-113.

5. 5. Bernier OM, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001;86:1568-1573.

6. 6. Hoie J, Saillant G, Hejblum G. Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer 1988;61:1-6.

7. 7. Herrera GA, Granados GM. Manual de Oncología, 2da. Mexico: Ed. McGraw-Hill;2002.

8. 8. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma. A multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.

9. 9. Pittas AG, Adler M, Farrazi M, Tickoo S, Rosai J, Larson SM, Robbins RJ. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 2000;10:261-268.

10. 10. Tubiana M, Habbad E, Schlumberger MJ, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer 1985;55:2062-2067.

11. 11. Marcocci C, Pacini F, Elisei R. Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989;106:960-966.

12. 12. Petrich T, Widjaja A, Musholt TJ, Hofmann M, Nrunkhorst T, Ehrenheim C, Oetting G, Knapp WH. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. Eur J Nuclear Med 2001;28:203-208.

13. 13. Lin JD, Huang MJ, Juang JH. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 1999;9:1227-1235.

14. 14. Niederle B, Roka R, Schemper M, Fritsch A, Weissel M, Ramach W. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery 1986;100:1088-1097.

15. 15. Casara D, Rubello D, Saladini G, Gallo V, Masarotto G, Busnardo B. Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori 1991;77:432-436.

16. 16. Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001;86:1568-1573.

17. 17. Dinneen SF, Valimaki MJ, Bergstralh EJ, Guellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995;80:2041-2045.